Both in Pharmaceuticals
Oric Pharmaceuticals vs MoonLake Immunotherapeutics
Over the past year ORIC returned −28.5% and MLTX returned +12.5%; their daily moves had a correlation of 0.32.
ORIC −28.5% MLTX +12.5%Growth of $1, one year, split-adjusted
| Metric | ORIC | MLTX |
|---|---|---|
| Price | $9.07 | $11.47 |
| Market cap | $940.1M | $976.2M |
| Today | −1.84% | −2.63% |
| 1 month | −25.7% | +0.5% |
| 6 months | −5.8% | −34.7% |
| Year to date | +10.9% | −13.0% |
| 1 year | −32.0% | +16.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $264.8M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 93.0% | 58.0% |
| Short % of float | 25.5% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).